Citadel Advisors’s SCYNEXIS SCYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,125
Closed -$10.9K 15442
2024
Q4
$10.9K Sell
1,125
-163
-13% -$1.69K ﹤0.01% 13576
2024
Q3
$15.3K Sell
1,288
-700
-35% -$9.9K ﹤0.01% 12969
2024
Q2
$31.8K Buy
+1,988
New +$30.7K ﹤0.01% 12207
2023
Q4
Sell
-188
Closed -$3.42K 15131
2023
Q3
$3.42K Sell
188
-2,300
-92% -$54.9K ﹤0.01% 13587
2023
Q2
$58.7K Sell
2,488
-562
-18% -$13.1K ﹤0.01% 11614
2023
Q1
$73.2K Sell
3,050
-1,225
-29% -$16.3K ﹤0.01% 11669
2022
Q4
$53.4K Buy
+4,275
New +$75.6K ﹤0.01% 12038
2022
Q3
Sell
-6,500
Closed -$97K 13500
2022
Q2
$97K Buy
6,500
+3,900
+150% +$75.1K ﹤0.01% 11440
2022
Q1
$81K Sell
2,600
-1,163
-31% -$44.5K ﹤0.01% 12472
2021
Q4
$184K Buy
3,763
+1,400
+59% +$68.9K ﹤0.01% 11973
2021
Q3
$100K Sell
2,363
-8,250
-78% -$432K ﹤0.01% 12865
2021
Q2
$625K Buy
10,613
+4,350
+69% +$274K ﹤0.01% 9519
2021
Q1
$398K Buy
+6,263
New +$411K ﹤0.01% 10186

Other funds holding SCYX

Citadel Advisors's SCYX Position: Q1 2026 in Review

Citadel Advisors increased its SCYNEXIS (SCYX) stake by 26% in Q1 2026, buying an estimated $20.8K and bringing the position to 16,354 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #11862.

Citadel Advisors first reported a position in SCYX in Q1 2017 and has held it in 18 quarters since. The position peaked at $431K in Q1 2021. 46 funds tracked by Wall St. Rank hold SCYX as of Q1 2026.

  • Citadel Advisors held 16,354 shares of SCYNEXIS worth $120K as of Q1 2026.
  • Citadel Advisors bought 3,362 SCYNEXIS shares in Q1 2026, an estimated $20.8K.
  • SCYNEXIS made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11862 holding.
  • Citadel Advisors first reported a position in SCYNEXIS in Q1 2017 and has held it in 18 quarters since.
  • Citadel Advisors's SCYNEXIS position peaked at $431K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held SCYNEXIS as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.